Johnson & Johnson (JNJ) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in New Brunswick, NJ, United States. Der aktuelle CEO ist Joaquin Duato.
JNJ hat IPO-Datum 1943-01-02, 138,100 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $578.62B.
Johnson & Johnson is a global healthcare company focused on innovative pharmaceuticals and medical devices following its 2023 strategic separation of its consumer health business into Kenvue Inc. The company's Innovative Medicine segment develops prescription medications for complex diseases including rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders. Its MedTech segment provides advanced medical technology solutions spanning electrophysiology, neurovascular care, orthopedic implants, surgical systems, and ACUVUE contact lenses. Operating worldwide and headquartered in New Brunswick, New Jersey, Johnson & Johnson serves hospitals, healthcare professionals, wholesalers, and retailers while maintaining its mission of advancing human health since 1886.
